 |
| |
Introduction
Over the past decade, vaccines have resurfaced as an attractive commercial proposition for Pharma. The developed world has been the initial focus of vaccine makers due to the better healthcare infrastructure and higher price levels. However, facing increasingly saturated markets in the West, companies are looking to expand into new geographies, such as Asia's emerging markets.
Scope
*Strategic analysis of key domestic vaccine companies as well as the position of major international players
*Thorough assessment of the market environment for vaccines in India, China, Taiwan and Korea
*Review of existing vaccine recommendations, coverage rates and promising future indications
*In-depth discussion of strengths, weaknesses, opportunities and threats for each market from a vaccine maker's perspective
Highlights
Immunizations in India are currently restricted to a limited public vaccination schedule, with the insufficient healthcare infrastructure in rural areas contributing to low coverage rates. Commercial opportunities lie in providing premium vaccines to the emerging private sector and in partnering with domestic players.
China is a very challenging market for international vaccine companies. The country remains difficult to penetrate due to the high language and cultural barriers, opaque regulatory environment and strong government influence. Local expertise and connections are crucial, making partnerships with domestic players a key strategy for market access.
With only one domestic vaccine player, Taiwan relies on imports. Looking to decrease the country's reliance on imports and to establish it as a hub for biotechnology, the Taiwanese government is encouraging international vaccine makers to build manufacturing and R&D facilities in the country, offering tax rebates and advance purchase agreements.
Reasons to Purchase
*Review portfolios and deals for key domestic vaccine companies as well as the position of major international vaccine makers
*Gain insight into the market environment for vaccines through a review of demographic, economic and regulatory trends
*Understand challenges, unmet needs and future opportunities by learning about the views of key opinion leaders from each country
Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan: http://www.companiesandmarkets.com/r.ashx?id=1MLWHTP5T187949
|
—
